Trial studying safety and effects for Atopic Dermatitis
Official title Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
ClinicalTrials.gov ID: NCT05575882
What this study is testing
- What it's testing
- Multicentric, double blind, randomized, comparative study with two parallel group: study group vs placebo group. 5 visits: inclusion visit [day (D) 0] and 4 follow-up visits (D30, D60, D90, and D120).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 15
You may be able to join if
- General criteria:
- Healthy subject (except AD and other atopic diseases - allergic rhinitis, conjunctivitis, and asthma). The subject can keep its usual treatment...
- Specific criteria:
- Sex: male or female. Age: from 6 months to 15 years. Subject having on average one flare-up per month during the four months preceding the study...
You likely can't join if
- Subject presenting cutaneous pathology in the studied zone other than AD (according to the investigator's appreciation, i.e., acne, psoriasis)...
The study team makes the final eligibility decision.
Where it's taking place
- Ciudad Autónoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Argentina
- New Delhi, India
- Singapore, Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 15 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ciudad Autónoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Argentina; New Delhi, India; Singapore, Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.